Table 1.
Demographic and clinical characteristics of all patients with nodular scleritis
| Clinical characteristics | Results |
|---|---|
| Age | 46.8±13.2 years |
| Median Duration of follow-up (Range) | 363.5 (90-5110) days |
| Gender | |
| Male | 36 (29.3) |
| Female | 87 (70.7) |
| Laterality | |
| Unilateral | 106 (86.2) |
| Bilateral | 17 (13.8) |
| Symptoms | |
| Ocular Pain | 85 (69.1%) |
| Foreign body sensations | 14 (11.3% ) |
| Redness | 114 (92.6%) |
| Watering | 3 (2.45) |
| Systemic association | |
| Rheumatoid arthritis | 6 (4.8%) |
| HLA-B27 - associated | 1 (0.8%) |
| Polymyositis | 1 (0.8%) |
| Granulomatosis polyangiitis | 1 (0.8%) |
| Behçet’s disease | 1 (0.8%) |
| Syphilis | 1 (0.8%) |
| Tuberculosis | 16 (13%) |
| Complications | |
| Anterior Uveitis | 8 (3.1%) |
| Ocular Hypertension | 11 (8.9%) |
| Cataract | 7 (5.7%) |
| Corneal involvement | 3 (2.4%) |
| Recurrences | 92 (74.8%) |
| Medications | |
| Topical NSAID | 26 (21.1%) |
| Oral NSAID | 16 (13.0%) |
| Oral Steroid | 97 (78.9%) |
| Topical Steroid | 101 (82.1%) |
| Immunosuppressives | |
| Cyclophosphamide | 7 (5.6%) |
| Methotrexate | 22 (17.8%) |
| Azathioprine | 10 (8.1%) |
| Mycophenolate mofetil | 21 (17.1%) |
NSAID=Nonsteroidal anti-inflammatory drug